Shares in Marksans Pharma crashed 20 per cent, after the company said that UK's MHRA has conducted a GMP inspection of the company's plant at Goa in the month of November 2015.
"Pursuant to the inspection, UK MHRA has issued certain observations which
Company has responded to. The Company is awaiting further response from UK MHRA in this matter as on date.
The company's Goa plant is functioning normally and the shipments to UK is
continuing in the normal course of business," the company said in a release to the exchanges.